Ad5 and Ad3 Chimeric Fiber Travels Into the Cell Without the CAR

Cancer Biology and Therapy - United States
doi 10.4161/cbt.2.5.520
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T Cells Upon Stimulation With Dendritic Cells Infected With a Modified Ad5 Vector Expressing a Chimeric Ad5/35 Fiber

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2004English

A Novel Ad5/11 Chimeric Oncolytic Adenovirus for Improved Glioma Therapy

International Journal of Oncology
Cancer ResearchOncology
2012English

The Travels of Monsieur De Thevenot Into the Levant.

1687English

An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer

American Journal of Hematology
Hematology
2019English

Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy

British Journal of Haematology
Hematology
2018English

Pcn301 - Health Technology Assessment for Chimeric Antigen Receptor (Car) T-Cell Therapies for Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Induced Pluripotent Stem (iPS) Cell–derived, Chimeric Antigen Receptor (CAR)-expressing T Cells for Immunotherapy

Science-Business eXchange
2013English

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Ensuring Center Quality, Proper Patient Selection and Fair Access to Chimeric Antigen Receptor T-Cell Therapy: Position Statement of the Austrian CAR-T Cell Network

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy